FIELD: biotechnology.
SUBSTANCE: disclosed is murine hybridoma YKL-40, clone 2G8 C10, collection number of GKPM-Obolensk H-90. Hybridoma is a producer of a monoclonal antibody specific for cytoplasmic human proteins YKL-39, YKL-40 and SI-CLP. Hybridoma-produced antibodies can potentially be used for diagnosing glioblastoma.
EFFECT: invention enables to obtain antibodies specifically detecting YKL-39, YKL-40 and SI-CLP by immunoassay, immunocytochemistry, immunohistochemistry, immunoblotting and immunofluorescence.
1 cl, 1 tbl, 3 ex, 5 dwg
Authors
Dates
2020-07-28—Published
2019-12-23—Filed